Follow the CLARITY PHARMACEUTICALS LTD stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are listed on AU AU, under the authority of ASX. Market capitalisation: €826.4m. The latest transaction was reported on 17 June 2026 (Initial Substantial Holding). Among the most active insiders: 2. Details of voting power. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
CLARITY PHARMACEUTICALS LTD is a company focused on developing innovative treatments for serious diseases. It is listed on the XASX market.